DBV Technologies

Cena Akcji
21.14
Dzienna Zmiana
-0.32 -1.49%
Miesięcznie
-2.45%
Rocznie
381.00%
Q1 Prognozy TE
20.91




Ebit Zmiana Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
DBV Technologies USD -34.28M 6.83M 2025-09
Esperion Therapeutics USD -16.03M 11.51M 2024-09
Galectin Therapeutics USD -9.17M 163K 2023-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD 389.3M 112.4M 2025-09


DBV Technologies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.